TG Therapeutics, Inc. (TGTX) ownership: Top institutional holder: BlackRock, Inc. ($739.24M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 22252930.00 | $739.24M | 2026-03-31 |
| VANGUARD GROUP INC | 15841002.00 | $472.22M | 2025-12-31 |
| STATE STREET CORP | 8649766.00 | $287.35M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8273979.00 | $274.86M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6603258.00 | $219.36M | 2026-03-31 |
| CONGRESS ASSET MANAGEMENT CO | 2600123.00 | $142.85M | 2026-06-30 |
| Soleus Capital Management, L.P. | 4029319.00 | $133.85M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3499916.00 | $116.29M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-01-28 | |
| Sell | null | 2026-01-28 | |
| Sell | null | 2026-01-08 |
Back to TGTX overview · TGTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.